Ginkgo (DNA) 10% Owner Canton Barry Receives RSU Awards

What Happened

• Canton Barry, a reported 10% owner of Ginkgo Bioworks Holdings, Inc. (DNA), was granted a total of 319,332 restricted stock units (RSUs) on July 28, 2026 (four separate awards of 35,736; 117,135; 39,038; and 127,423 RSUs). The filing lists these as award/grant transactions (code A) and shows no cash price (N/A) because these are derivative awards, not open-market trades.

Key Details

• Transaction date: July 28, 2026; Form 4 filed July 30, 2026 (timely filing).
• Amounts granted: 35,736; 117,135; 39,038; and 127,423 RSUs — total 319,332 RSUs.
• Price/consideration: N/A (RSUs are non-cash equity awards).
• Shares owned after transaction: not specified in the provided excerpt of the filing.
• Footnotes: F1 — each RSU converts to one share of Class A common stock upon vesting; F2 — one tranche vests 75% on Oct 16, 2026 and 25% on Jan 21, 2027; F3 — another tranche vests in equal quarterly installments over the next 12 quarters beginning Oct 16, 2026.
• Insider status: Barry is a 10% owner (statutory insider), so this is a significant holder’s compensation grant rather than an executive open-market purchase or sale.

Context

• RSUs are compensation awards that convert to shares only after vesting; they are not an immediate purchase or sale and do not directly indicate buying interest. Because vesting is staggered (large portions in Oct 2026/Jan 2027 and the balance across 12 quarters), any potential share receipt or subsequent sales would occur later when vesting occurs.
• For retail investors, note that awards are routine compensation/retention tools and differ from open-market purchases (which some interpret as a stronger bullish signal). Track future Form 4 filings around vesting dates for any sale or transfer of the issued shares.